| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10917956 | Radiotherapy and Oncology | 2015 | 4 Pages |
Abstract
A device for MRI-guided radiation therapy (MR-IGRT) that uses cobalt-60 sources to deliver intensity modulated radiation therapy is now commercially available. We investigated the performance of the treatment planning and delivery system against the benchmark recommended by the American Association of Physicists in Medicine (AAPM) Task Group 119 for IMRT commissioning and demonstrated that the device plans and delivers IMRT treatments within recommended confidence limits and with similar accuracy as linac IMRT.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
H. Omar Wooten, Vivian Rodriguez, Olga Green, Rojano Kashani, Lakshmi Santanam, Kari Tanderup, Sasa Mutic, H. Harold Li,